Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
62 hedge funds and large institutions have $250M invested in Oxford Immunotec Global PLC Ordinary Shares in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 21 increasing their positions, 23 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
2% more funds holding
Funds holding: 61 → 62 (+1)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1% less capital invested
Capital invested by funds: $252M → $250M (-$2.26M)
9% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$2.66M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
+$2.38M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$1.7M |
| 4 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
+$1.44M |
| 5 |
Axa
Paris,
France
|
+$1.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WSA
Wall Street Associates
Lajolla,
California
|
-$3.22M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$2.5M |
| 3 |
TCM
Tamarack Capital Management
Carlsbad,
California
|
-$1.76M |
| 4 |
DM
Deerfield Management
New York
|
-$563K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$416K |
OXFD Hedge Fund Activity: Q3 2015 in Review
62 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q3 2015, worth a combined $250M — down 0.9% from $252M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new OXFD positions and 3 closed out — a net gain of 1 holder — while 21 added to existing stakes and 23 trimmed.
The largest buyer was Waddell & Reed Financial, opening a new position worth an estimated $2.66M. The largest seller was Wall Street Associates, cutting an estimated $3.22M.
- 62 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q3 2015, up from 61 in Q2 2015.
- Funds reported $250M of Oxford Immunotec Global PLC Ordinary Shares stock for Q3 2015, down 0.9% quarter-over-quarter.
- 4 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q3 2015 and 3 closed out, a net change of +1 holder.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q3 2015 was Waddell & Reed Financial, an estimated $2.66M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q3 2015 was Wall Street Associates, an estimated $3.22M sold.
Based on aggregated 13F filings for Q3 2015.